Towards Healthcare
CRISPR Market Size Hits USD 3.27 Billion in 2025

CRISPR Market Insights Services Segment Rising Fast as Ex Vivo Dominates

According to market projections, the CRISPR sector is expected to grow from USD 2.94 billion in 2024 to USD 8.58 billion by 2034, reflecting a CAGR of 11.24%. The market is growing due to rising demand for gene-editing therapies in genetic disorders and cancer treatment. Advancements in biotechnology and increased R&D investments are further accelerating its adoption across healthcare and agriculture.

Content

  • Last Updated: 01 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The CRISPR market is projected to reach USD 8.58 billion by 2034, growing at a CAGR of 11.24% from 2024 to 2034.

North America is currently leading the CRISPR market due to its strong biotechnology infrastructure, significant government and private funding, and presence of key market players.

he CRISPR market includes 6 segments by product type, by application, by end user, by therapeutic application, by delivery method, and by region.

Some key players include Synthego Corporation, Horizon Discovery, ToolGen, Inc., Inscripta, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc.

Key trends include the growth due to rising demand for gene-editing therapies in genetic disorders and cancer treatment.

CRISPR is being tested for treating genetic diseases like sickle cell anemia, beta-thalassemia, certain cancers, and rare metabolic disorders.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions